CORD-19:a44cd4fe9a7c450cf0e3e0fe955d43f824bb3ebe / 34460-34702 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T200","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The modified murine CCL2 gene, with replacement of the mRNA cap site, was obtained from Dr. Barrett Rollins (Dana Farber Cancer Institute, Boston, MA) and was placed under the control of the hGFAP promoter to produce the hGFAP-CCL2 transgene."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T200","span":{"begin":0,"end":242},"obj":"Sentence"}],"text":"The modified murine CCL2 gene, with replacement of the mRNA cap site, was obtained from Dr. Barrett Rollins (Dana Farber Cancer Institute, Boston, MA) and was placed under the control of the hGFAP promoter to produce the hGFAP-CCL2 transgene."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T39","span":{"begin":121,"end":127},"obj":"Phenotype"}],"attributes":[{"id":"A39","pred":"hp_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"The modified murine CCL2 gene, with replacement of the mRNA cap site, was obtained from Dr. Barrett Rollins (Dana Farber Cancer Institute, Boston, MA) and was placed under the control of the hGFAP promoter to produce the hGFAP-CCL2 transgene."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T98","span":{"begin":121,"end":127},"obj":"Disease"},{"id":"T7823","span":{"begin":121,"end":127},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A33145","pred":"mondo_id","subj":"T7823","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"The modified murine CCL2 gene, with replacement of the mRNA cap site, was obtained from Dr. Barrett Rollins (Dana Farber Cancer Institute, Boston, MA) and was placed under the control of the hGFAP promoter to produce the hGFAP-CCL2 transgene."}